Legend Biotech (LEGN) Return on Sales (2019 - 2025)

Legend Biotech (LEGN) has reported Return on Sales for 7 consecutive years, with 0.0% the latest figure, recorded in Q4 2025.

• Return on Sales for Q4 2025 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Sales was 0.0% for Q4 2025 at Legend Biotech, up from 0.0% in the prior quarter.
• Over five years, Return on Sales peaked at 0.2% in Q3 2022 and troughed at 0.16% in Q2 2022.
• Average Return on Sales over 5 years is 0.01%, with a median of 0.01% recorded in 2024.
• The widest YoY moves for Return on Sales: up 27 bps in 2022, down 25 bps in 2022.
• Over 5 years, Return on Sales stood at 0.11% in 2021, then surged by 53 bps to 0.05% in 2022, then soared by 100 bps to 0.0% in 2023, then jumped by 15975 bps to 0.0% in 2024, then plunged by 109 bps to 0.0% in 2025.
• Per Business Quant data, the three most recent Return on Sales figures were 0.0% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.